|Cancer Patient Safety Framework - Managing Adherence to Oral Therapies|
The Cancer Patient Safety Framework – Managing Adherence to Oral Therapies program addresses the growing challenge of adherence to oral therapies and will allow participants to gain an understanding of the impact of oral therapies in oncology care, discuss the risk factors associated with over and under adherence to therapy, and implement tools within their practice to promote adherence. This project was supported by Novartis.
Questions or comments? Email us at email@example.com
Disclaimer: This document contains information prepared by the International Society of Nurses in Cancer Care (ISNCC) for the international oncology nursing community. Although due care has been used in the preparation of these materials, ISNCC makes no representation or warranty, express or implied that it is free from errors or omissions, or that it is exhaustive, and expressly disclaims all warranties, including but not limited to, warranties as to the information’s quality or fitness for a particular purpose. The information contained herein is not intended to supplant the clinical judgment of qualified medical professionals. ISNCC and its directors, officers, employees, members, representatives, and agents accept no liability for any loss, cost, expense, injury, or damages, whether direct, indirect, incidental, consequential, special, or other, arising from the application of the information contained in this document for patient care or any other use. The accuracy of the information contained herein is subject to changes in circumstances after the time of publication. ISNCC accepts no responsibility for the accuracy and reliability of information provided by third parties. Further, ISNCC accepts no responsibility for the accuracy and reliability of these materials after language translation.
Nurse Prescribing for Pain
2/13/2017 » 2/14/2017
MEDICRES INTERNATIONAL CONFERENCE GOOD BIOSTATISTICAL & PUBLICATION PRACTICE
4/26/2017 » 4/29/2017
XVI International Symposium on Oncology Pharmacy Practice (ISOPP 2017)